(Q46517338)

22 December 2017

title

Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: a quality improvement programme (English)

1 reference

22 December 2017

1 reference

D Taylor

5

0 references

author name string

T R E Barnes

1

1 reference

22 December 2017

C Paton

2

1 reference

22 December 2017

E Hancock

3

1 reference

22 December 2017

M-R Cavanagh

4

1 reference

22 December 2017

P Lelliott

6

1 reference

22 December 2017

UK Prescribing Observatory for Mental Health

7

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 July 2008

1 reference

22 December 2017

Acta Psychiatrica Scandinavica

published in

1 reference

22 December 2017

volume

118

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

26-33

1 reference

22 December 2017

Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Rsearch Database

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

Hepatic insulin resistance in antipsychotic naive schizophrenic patients: stable isotope studies of glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

Undiagnosed impaired fasting glucose and diabetes mellitus amongst inpatients receiving antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

Epidemiology and treatment of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

A UK audit of screening for the metabolic side effects of antipsychotics in community patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

Testing for diabetes in hospitalised patients prescribed antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

Guidelines for computer modeling of diabetes and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

Audit and feedback: effects on professional practice and health care outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

Continuing education meetings and workshops: effects on professional practice and health care outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

Implementing clinical guidelines: current evidence and future implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

Obesity and metabolic syndrome in a psychiatric rehabilitation service.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

Does antipsychotic polypharmacy increase the risk for metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

Hypertension and ethnic group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

How does ethnicity affect the association between obesity and diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2008.01203.X

10.1111/J.1600-0447.2008.01203.X

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

18582345

1 reference

22 December 2017